IME vs NOX

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IME

IMEXHS FPO [IME]

50MEDIUM

NOX

NOXOPHARM FPO [NOX]

50MEDIUM

Score Breakdown

IME NOX
Technical
66
54
Catalyst
50
50
Sentiment
50
50
Fundamental
88
29
Momentum
69
60
Risk Gate
35
43

Key Metrics

IME Metric NOX
$21.6MMarket Cap$19.7M
N/AAvg Volume (20d)81K
N/AShort InterestN/A
$0.47052-Week High$0.135
$0.22052-Week Low$0.043
+0.0%Daily Change+6.7%
$0.400Entry Price$0.064
-19.0%ROE-343.6%
-9.9%Profit Margin-161.7%

Active Signals

IME Signals

●RSI drifting toward oversold territory — worth watching
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (0.7x)
●Strong revenue growth (+21%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

NOX Signals

●MACD momentum is picking up steam
●Volume surging at 4.1x normal while price falls — heavy selling pressure
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.1 quarters)
●Moderate P/S ratio (5.8x)
●Strong revenue growth (+50%)
●Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare IME and NOX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IME Full Analysis → NOX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).